2017
DOI: 10.3389/fnana.2017.00065
|View full text |Cite
|
Sign up to set email alerts
|

Pseudotyped Lentiviral Vectors for Retrograde Gene Delivery into Target Brain Regions

Abstract: Gene transfer through retrograde axonal transport of viral vectors offers a substantial advantage for analyzing roles of specific neuronal pathways or cell types forming complex neural networks. This genetic approach may also be useful in gene therapy trials by enabling delivery of transgenes into a target brain region distant from the injection site of the vectors. Pseudotyping of a lentiviral vector based on human immunodeficiency virus type 1 (HIV-1) with various fusion envelope glycoproteins composed of di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3
2

Relationship

2
8

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 61 publications
0
16
0
Order By: Relevance
“…The following virus vectors were used: fusion glycoprotein Type E (FuG-E)tetracycline-responsive element (TRE)-enhanced green fluorescent protein (EGFP)-enhanced tetanus neurotoxin light chain (eTeNT) (titer, 2.2-2.4 ϫ 10 12 copies/ml), FuG-E-murine stem cell virus (MSCV)-Cre (titer, 6.5 ϫ 10 10 copies/ml), adeno-associated virus (AAV)-DJcytomegalovirus (CMV)-reverse tetracycline transactivator (rtTAV16) (titer, 5.8 -6.8 ϫ 10 10 copies/ml), and AAV-DJ-elongation factor 1-␣ (EF1␣)-DIO-hM4D(Gi)-mCherry (titer, 5.0 ϫ 10 9 copies/ml). The FuG-E-pseudotyped vector was modified from a previously reported an HIV Type 1 (HIV-1)-based vector to produce enhanced efficiency of retrograde gene delivery (Kato et al, 2014;Kobayashi et al, 2017). FuG-E-TRE-EGFP-eTeNT and AAV-DJ-CMV-rtTAV16, comprising the Tet-on system, were used to blockade the cortico-rubral tract.…”
Section: Methodsmentioning
confidence: 99%
“…The following virus vectors were used: fusion glycoprotein Type E (FuG-E)tetracycline-responsive element (TRE)-enhanced green fluorescent protein (EGFP)-enhanced tetanus neurotoxin light chain (eTeNT) (titer, 2.2-2.4 ϫ 10 12 copies/ml), FuG-E-murine stem cell virus (MSCV)-Cre (titer, 6.5 ϫ 10 10 copies/ml), adeno-associated virus (AAV)-DJcytomegalovirus (CMV)-reverse tetracycline transactivator (rtTAV16) (titer, 5.8 -6.8 ϫ 10 10 copies/ml), and AAV-DJ-elongation factor 1-␣ (EF1␣)-DIO-hM4D(Gi)-mCherry (titer, 5.0 ϫ 10 9 copies/ml). The FuG-E-pseudotyped vector was modified from a previously reported an HIV Type 1 (HIV-1)-based vector to produce enhanced efficiency of retrograde gene delivery (Kato et al, 2014;Kobayashi et al, 2017). FuG-E-TRE-EGFP-eTeNT and AAV-DJ-CMV-rtTAV16, comprising the Tet-on system, were used to blockade the cortico-rubral tract.…”
Section: Methodsmentioning
confidence: 99%
“…Modulating virus reservoir is essential to prevent HSK from recurrence. Our study showed preliminary evidence of retrograde transportation of HELP from corneas to TG using VSV-G pseudotyping, however, enhanced retrograde delivery may be achieved by pseudotyping HELP with derivatives of rabies virus glycoprotein, which may further strengthen the efficacy of HELP in clinical studies 31,32 .…”
Section: Figurementioning
confidence: 68%
“…To achieve selective initial infection of VON neurons by the rabies virus, we used the neural pathway specific-tracing method (tracing the relationship between input and output, TRIO 26 ). We first injected a retrograde Cre-coding lentiviral vector (NeuRet-Cre 27 ) into the LH, and Cre-dependent AAV vectors encoding TVA-mCherry and rabies G into the VON. Two weeks after the injection, we injected the modified rabies virus (SAD-dG-EGFP+EnvA) into the VON (Fig.…”
Section: Resultsmentioning
confidence: 99%